SKAN Group AG (SWX:SKAN)
Switzerland · Delayed Price · Currency is CHF 58.50
0.00 (0.00%)
Aug 3, 2026, 4:14 PM CET
SKAN Group AG Market Cap
SKAN Group AG has a market cap or net worth of 1.32 billion as of August 3, 2026. Its market cap has decreased by -21.79% in one year.
Market Cap
1.32B
Enterprise Value
1.37B
Revenue
333.34M
Ranking
n/a
PE Ratio
80.82
Stock Price
58.50
ChartMarket Cap Chart
Since April 10, 2007, SKAN Group AG's market cap has increased from 47.48M to 1.32B, an increase of 2,669.92%. That is a compound annual growth rate of 18.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.32B | 10.80% |
| Dec 30, 2025 | 1.19B | -30.71% |
| Dec 30, 2024 | 1.71B | -5.69% |
| Dec 29, 2023 | 1.82B | 28.25% |
| Dec 30, 2022 | 1.42B | -28.89% |
| Dec 30, 2021 | 1.99B | 1,168.29% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 282.15B |
| Novartis AG | 240.97B |
| Galderma Group AG | 42.37B |
| Lonza Group AG | 39.83B |
| Tecan Group AG | 2.34B |
| Idorsia | 1.58B |
| PolyPeptide Group AG | 1.45B |
| Aevis Victoria | 1.12B |